Guardant Health’s precision oncology tests - Guardant Reveal
TM
, Guardant360® CDx, and Guardant360 TissueNext
TM
are now available from Codex Genetics.
Bioinformatics
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Pan-Cancer Marker Test
Congenital Cardiovascular Disease
Metagenomics
Retinitis Pigmentosa
Professionals
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
Sign up
Sign In
Bioinformatics
Products & Services
Products & Services
Hereditary Cancer Test
Neurodegenerative Disease Test
Drug Response Test
Pan-Cancer Marker Test
Congenital Cardiovascular Disease
Metagenomics
Retinitis Pigmentosa
Professionals
About Us
About Us
Codex Cares
News and Events Hub
Blog
Careers
中文
Sign Up
Login
#breast-cancer
Why should breast cancer patients confirm PIK3CA mutation?
Date：2021-12-14
Breast cancer genetic risk: Is it enough to test BRCA1 and BRCA2 genes only?
Date：2021-12-14
Companion Diagnostics: integration of Diagnostic Testing into Treatment Pathway
Date：2021-12-13
US Expert Medical Opinion: Genetic Testing Should Be Performed on All Newly Diagnosed Breast Cancer Patients
Date：2021-04-19
Early Detection of BRCA Gene Mutations and Tackle the Refractory Triple-Negative Breast Cancer
Date：2020-10-07
Breast Self-Exam may not be Effective! Learn about different Breast Cancer Screening Methods
Date：2020-10-07
Breast Cancer Risk Factors that Cannot be Underestimated: Prevent Breast Cancer by Understanding the Risks
Date：2020-10-07
Is Breast Cancer Hereditary? Know more about BRCA Gene Mutation
Date：2020-10-07
We use cookies to ensure that you have the best experience on our website. If you continue to use this site we assume that you accept this.
OK
